Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes

Clinical trial NCT02281084 · COMPLETED

Trial details

NCT number: NCT02281084
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2015-07-06
Primary completion: 2019-06-19
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.